Acute myeloid leukemia (AML) is a progressive type of cancer that affects your bone marrow and blood cells. Early detection and treatment are important to help increase the chances of survival from ...

The overall 5-year relative survival rate for AML is about 30%, but this number is an estimate based on a large group of people and does not predict individual outcomes. Younger people with AML tend ...

AML is a genetically heterogeneous disease, particularly in older patients. In patients older than 60 years, survival rates are variable after the most important curative approach, intensive ...

A chromosome is a package of DNA that exists inside the nucleus of a cell. A karyotype refers to the unique collection of chromosomes present in a person’s cells. Acute myeloid leukemia (AML) is a ...

As consolidation therapy for acute myeloid leukemia (AML), allogeneic hematopoietic stem-cell transplantation provides a benefit in part by means of an immune-mediated graft-versus-leukemia effect. We ...

Defining the Role of Donor Lymphocyte Infusion in High-Risk Hematologic Malignancies Current data highlight the potential role for immunotherapy in AML. Gaps in knowledge include limited studies on ...